Literature DB >> 3146604

[Susceptibilities of recent clinical isolates of Rickettsia tsutsugamushi to chemotherapeutic agents in vitro].

H Urakami, A Tamura, S Miyamura, S Yamamoto, N Kawabata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3146604     DOI： 10.11150/kansenshogakuzasshi1970.62.931

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN： 0387-5911


× No keyword cloud information.
  4 in total

Review 1.  Antimicrobial therapy of rickettsial diseases.

Authors:  D Raoult; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

2.  Orientia tsutsugamushi Is Highly Susceptible to the RNA Polymerase Switch Region Inhibitor Corallopyronin A In Vitro and In Vivo.

Authors:  Fredericke Kock; Matthias Hauptmann; Anke Osterloh; Till F Schäberle; Sven Poppert; Hagen Frickmann; Klaus-Dieter Menzel; Gundela Peschel; Kenneth Pfarr; Andrea Schiefer; Gabriele M König; Achim Hoerauf; Bernhard Fleischer; Christian Keller
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

3.  In vitro bacteriostatic effects of rifampin on Orientia tsutsugamushi.

Authors:  Jae-Hyoung Im; Ji Hyeon Baek; Jin-Soo Lee; Moon-Hyun Chung; Sun Myoung Lee; Jae-Seung Kang
Journal:  J Korean Med Sci       Date:  2014-01-28       Impact factor: 2.153

4.  Novel high-throughput screening method using quantitative PCR to determine the antimicrobial susceptibility of Orientia tsutsugamushi clinical isolates.

Authors:  Weerawat Phuklia; Phonepasith Panyanivong; Davanh Sengdetka; Piengchan Sonthayanon; Paul N Newton; Daniel H Paris; Nicholas P J Day; Sabine Dittrich
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.